The same GLP-1 activity that supports appetite control can also slow gastric emptying, meaning food moves more slowly through the stomach
Such inconsistency may raise questions regarding reliability
27 Plateaus on GLP-1 medications like semaglutide often occur after a period of successful weight loss, typically estimated between 9 and 12 months 46 or around 60 weeks of treatment
After accounting for a wide range of potentially influential factors including patient age, sex, socioeconomic status, diabetes severity, and a history of mental ill health, use of GLP-1 receptor agonists was not associated with an increased risk of suicidality compared with DPP-4 inhibitors (3.9 v 3.7 per 1000 person years, respectively) or an increased risk of suicidality compared with SGLT-2 inhibitors (4.3 v 4.6 per 1000 person years, respectively)
Atherosclerosis with multiple and diverse drivers is a dominant complicating process in T2DM [53]
doi: 10.1007/s11427-023-2305-0 29